Crossmark

Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-018-2487-9

Published Online: 2018-02-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Habib Rehman

Kralj-Hans, Ines

Haldar, Shouvik

Bahrami, Toufan

Clague, Jonathan

De Souza, Anthony

Francis, Darrel

Hussain, Wajid

Jarman, Julian

Jones, David Gareth

Mediratta, Neeraj

Mohiaddin, Raad

Salukhe, Tushar

Jones, Simon

Lord, Joanne

Murphy, Caroline

Kelly, Joanna

Markides, Vias

Gupta, Dhiraj

Wong, Tom
Funding

Funding for this research was provided by:

Efficacy and Mechanism Evaluation Programme (12/127/127)
More Information

Article History

Received: 29 May 2017

Accepted: 22 January 2018

First Online: 20 February 2018

Ethics approval and consent to participate

: The study received ethical approval from the Bristol Research Ethics Committee Centre (NRES Committee South Central - Oxford A) on 5 March 2015 (REC reference []/SC/0023). All study participants are asked to sign a written informed consent form before taking part in the study.

: Not applicable.

: HRK’s salary was funded by the CASA-AF Trial. HRK has a non-financial competing interest for using data for a higher post-graduate degree. VM is a consultant for Biosense Webster. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below